New LaunchMay 8, 2026, 08:03 AM
MIMEDX Launches G4Derm Plus for Advanced Wound Management
AI Summary
MIMEDX Group, Inc. announced the commercial launch of G4Derm Plus, an innovative 510(k)-cleared flowable biomimetic matrix for advanced wound management. The company secured exclusive U.S. distribution rights for this self-assembling peptide technology, expanding its portfolio for surgical markets. G4Derm Plus is now available through Premier and Vizient GPO agreements, facilitating a national launch and providing clinicians with a new solution for complex wounds.
Key Highlights
- MIMEDX commercially launched G4Derm Plus nationwide.
- Company acquired exclusive U.S. distribution rights for G4Derm Plus.
- G4Derm Plus is a 510(k)-cleared solution for advanced wound management.
- Product added to Premier and Vizient Group Purchasing Organization (GPO) agreements.
- G4Derm Plus utilizes self-assembling peptide technology to form a 3D scaffold.
Price Impact
More from MDXG